<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30073103</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">2090-6706</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>2018</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Case reports in oncological medicine</Title>                <ISOAbbreviation>Case Rep Oncol Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature Review.</ArticleTitle>            <Pagination>                <MedlinePgn>4714708</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/4714708</ELocationID>            <Abstract>                <AbstractText>Gastric linitis plastica is a diffuse involvement of the stomach walls by neoplastic cells. It represents about 3-19% of primitive gastric adenocarcinomas, but it can also be the manifestation of a metastatic disease. Breast cancer is the most frequent malignancy in women, and the metastatic spread to the stomach occurs in less than 10% of the cases. We present an unusual case of gastric linitis plastica and peritoneal carcinomatosis as manifestations of an occult breast cancer in a 53-year-old woman. Imaging and endoscopic evaluation were not able to discriminate a primary from a secondary gastric lesion. The histological evaluation excluded the diagnosis of a primary gastric neoplasia. The IHC profile was consistent with the diagnosis of metastases from the breast cancer. Due to the hormonal receptors' positivity, we started therapy with fulvestrant (500â€‰mg, day 0, 14, and 28 and every 28 days thereafter by intramuscular injection). After 20 months, the same therapy is still ongoing and well tolerated, while the patient is in good condition with improvement of the dysphagia. Almost 2 years after the diagnosis of linitis plastica, the primitive breast lesion is still occult.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Mantiero</LastName>                    <ForeName>Mara</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">0000-0002-1016-4995</Identifier>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Faggioni</LastName>                    <ForeName>Giovanni</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Menichetti</LastName>                    <ForeName>Alice</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fassan</LastName>                    <ForeName>Matteo</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, Surgical Pathology &amp; Cytopathology Unit, University of Padova, Padova, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guarneri</LastName>                    <ForeName>Valentina</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Conte</LastName>                    <ForeName>Pierfranco</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Medical Oncology Unit 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>08</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Case Rep Oncol Med</MedlineTA>            <NlmUniqueID>101581035</NlmUniqueID>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2015 Sep;26 Suppl 5:v133-8</RefSource>                <PMID Version="1">26314775</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Mar 1;34(7):e54-6</RefSource>                <PMID Version="1">24982453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1995 Aug;13(8):2094-103</RefSource>                <PMID Version="1">7636553</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2001 Oct 15;61(20):7388-93</RefSource>                <PMID Version="1">11606367</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2000 Dec 1;89(11):2214-21</RefSource>                <PMID Version="1">11147591</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1986 Apr 1;57(7):1376-9</RefSource>                <PMID Version="1">3948119</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Intern Med. 1988 Sep;148(9):2035-9</RefSource>                <PMID Version="1">3046543</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 1996 Sep;29(3):233-40</RefSource>                <PMID Version="1">8884351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Rev Esp Enferm Dig. 2008 Jul;100(7):440-2</RefSource>                <PMID Version="1">18808296</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gastroenterol Hepatol. 2007 Apr;22(4):601-2</RefSource>                <PMID Version="1">17376062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Pathol. 1989 Mar;20(3):281-7</RefSource>                <PMID Version="1">2542151</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Surg Today. 1992;22(5):421-5</RefSource>                <PMID Version="1">1421863</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 May 21;9(5):e98127</RefSource>                <PMID Version="1">24848085</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Surg Case Rep. 2011;2(8):301-5</RefSource>                <PMID Version="1">22096760</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2014 Jan;232(1):23-31</RefSource>                <PMID Version="1">24122263</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gastrointest Endosc. 1992 Mar-Apr;38(2):130-5</RefSource>                <PMID Version="1">1568608</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1984 Jul;50(1):23-30</RefSource>                <PMID Version="1">6331484</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fam Cancer. 2016 Apr;15(2):215-9</RefSource>                <PMID Version="1">26759166</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Care (Basel). 2008;3(3):164-170</RefSource>                <PMID Version="1">20824034</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>05</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30073103</ArticleId>            <ArticleId IdType="doi">10.1155/2018/4714708</ArticleId>            <ArticleId IdType="pmc">PMC6057327</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>